Devansh Mishra’s Latest Research Highlights Hypercoagulable State in COPD
Devansh Mishra, Associate at Trainee Research AssoCiation of KGMU (TRACK), shared a post on LinkedIn:
“New Publication Alert!
Thrilled to share our latest research article, “Evaluation of Prothrombotic Biomarkers in Stable and Exacerbation Phases of Chronic
Obstructive Pulmonary Disease: A Cross-Sectional Study,” published in Cureus.
Chronic Obstructive Pulmonary Disease (COPD) remains a major global health burden, and acute exacerbations (AECOPD) significantly worsen morbidity and mortality. Our study explores the role of prothrombotic biomarkers—fibrinogen, CRP, D-dimer, and vWF—in identifying and differentiating stable and exacerbation phases of COPD.
We found that AECOPD is associated with a distinct hypercoagulable state, emphasizing the growing evidence that inflammation and thrombosis are tightly linked in disease progression. These findings not only shed light on potential diagnostic and prognostic biomarkers but also open pathways for early risk stratification and targeted therapy.
Grateful to my mentors Prof. Virendra Atam sir, Prof. Shyam chand Chaudhary sir, and Dr. Jay Tewari boss for their invaluable guidance and support throughout this work.
Proud to contribute to the evolving understanding of COPD pathophysiology and its clinical management.”
Title: Evaluation of Prothrombotic Biomarkers in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease: A Case-Control Study
Authors: Kamlesh K. Gupta, Shantanu Singh, Virendra Atam, Devansh Mishra, Jay Tewari, Shyam C. Chaudhary, Ajay Patwa
Read full article here
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE
-
Nov 2, 2026, 12:31Toby Richards: Screening for Iron Deficiency – Nearly 1 in 4 Women Anaemic